Inventor

WILLERT ERIN

US22 patents

⚠️ This page may combine multiple inventors who share the name “WILLERT ERIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

WILLERT ERIN

MOLECULAR TEMPLATES INC

Cell-targeting molecules comprising protease-cleavage resistant, Shiga toxin A subunit effector polypeptides and carboxy-terminal moieties

MHC class I epitope delivering polypeptides

Shiga toxin a subunit effector polypeptides, Shiga toxin effector scaffolds, and cell-targeting molecules for site-specific conjugation

Methods of screening, selecting, and identifying cytotoxic recombinant polypeptides based on an interim diminution of ribotoxicity

De-immunized, Shiga toxin a subunit scaffolds and cell-targeting molecules comprising the same

PD-L1 -binding molecules comprising Shiga toxin A subunit scaffolds

Shiga toxin A subunit effector polypeptides, Shiga toxin effector scaffolds, and cell-targeting molecules for site-specific conjugation

HER2-targeting molecules comprising de-immunized, Shiga toxin A subunit scaffolds

Cell-targeting molecules comprising de-immunized, Shiga toxin a subunit effectors and CD8+ t-cell epitopes

Multivalent CD20-binding molecules comprising Shiga toxin A subunit effector regions and enriched compositions thereof

MHC class I epitope delivering polypeptides

CD20-binding proteins comprising Shiga toxin A subunit effector regions for inducing cellular internalization and methods using same

CD20-binding immunotoxins for inducing cellular internalization and methods using same

Multivalent CD20-binding molecule comprising Shiga toxin A subunit effector polypeptides and enriched compositions thereof

Multivalent CD20-binding molecules comprising Shiga toxin a subunit effector regions and enriched compositions thereof

De-immunized Shiga toxin a subunit effector polypeptides for applications in mammals

PD-L1-binding molecules comprising Shiga toxin a subunit scaffolds

Clinical methods for use of a PD-L1-binding molecule comprising a Shiga toxin effector

MILLENNIUM PHARM INC

Anti-CD38 binding domains

CD38-binding proteins comprising de-immunized Shiga toxin A subunit effectors

MILENNIUM PHARMACEUTICALS INC

CD38-binding proteins comprising de-immunized Shiga toxin A subunit effectors

TAKEDA PHARMACEUTICALS CO

Anti-CD38 binding domains